616 related articles for article (PubMed ID: 24831822)
21. Effectiveness and cost-effectiveness of computer and other electronic aids for smoking cessation: a systematic review and network meta-analysis.
Chen YF; Madan J; Welton N; Yahaya I; Aveyard P; Bauld L; Wang D; Fry-Smith A; Munafò MR
Health Technol Assess; 2012; 16(38):1-205, iii-v. PubMed ID: 23046909
[TBL] [Abstract][Full Text] [Related]
22. Nicotinic receptor partial agonists as novel compounds for the treatment of smoking cessation.
Tutka P
Expert Opin Investig Drugs; 2008 Oct; 17(10):1473-85. PubMed ID: 18808308
[TBL] [Abstract][Full Text] [Related]
23. 'Cut down to quit' with nicotine replacement therapies in smoking cessation: a systematic review of effectiveness and economic analysis.
Wang D; Connock M; Barton P; Fry-Smith A; Aveyard P; Moore D
Health Technol Assess; 2008 Feb; 12(2):iii-iv, ix-xi, 1-135. PubMed ID: 18093448
[TBL] [Abstract][Full Text] [Related]
24. Cytisine Versus Varenicline for Smoking Cessation in a Primary Care Setting: A Randomized Non-inferiority Trial.
Oreskovic T; Percac-Lima S; Ashburner JM; Tiljak H; Rifel J; Klemenc Ketiš Z; Oreskovic S
Nicotine Tob Res; 2023 Aug; 25(9):1547-1555. PubMed ID: 37291049
[TBL] [Abstract][Full Text] [Related]
25. Cost-effectiveness analysis of varenicline versus existing smoking cessation strategies in Central America and the Caribbean using the BENESCO model.
Lutz MA; Lovato P; Cuesta G
Hosp Pract (1995); 2012 Feb; 40(1):24-34. PubMed ID: 22406880
[TBL] [Abstract][Full Text] [Related]
26. Cytisine versus varenicline for smoking cessation for Māori (the indigenous people of New Zealand) and their extended family: protocol for a randomized non-inferiority trial.
Walker N; Smith B; Barnes J; Verbiest M; Kurdziel T; Parag V; Pokhrel S; Bullen C
Addiction; 2019 Feb; 114(2):344-352. PubMed ID: 30276931
[TBL] [Abstract][Full Text] [Related]
27. Interventions for smoking cessation and reduction in individuals with schizophrenia.
Tsoi DT; Porwal M; Webster AC
Cochrane Database Syst Rev; 2013 Feb; 2013(2):CD007253. PubMed ID: 23450574
[TBL] [Abstract][Full Text] [Related]
28. A discrete-event simulation of smoking-cessation strategies based on varenicline pivotal trial data.
Xenakis JG; Kinter ET; Ishak KJ; Ward AJ; Marton JP; Willke RJ; Davies S; Caro JJ
Pharmacoeconomics; 2011 Jun; 29(6):497-510. PubMed ID: 21452908
[TBL] [Abstract][Full Text] [Related]
29. Antidepressants for smoking cessation.
Hajizadeh A; Howes S; Theodoulou A; Klemperer E; Hartmann-Boyce J; Livingstone-Banks J; Lindson N
Cochrane Database Syst Rev; 2023 May; 5(5):CD000031. PubMed ID: 37230961
[TBL] [Abstract][Full Text] [Related]
30. Cost-Effectiveness Analysis of Smoking Cessation Interventions in the United Kingdom Accounting for Major Neuropsychiatric Adverse Events.
Keeney E; Welton NJ; Stevenson M; Dalili MN; López-López JA; Caldwell DM; Phillippo DM; Munafò MR; Thomas KH
Value Health; 2021 Jun; 24(6):780-788. PubMed ID: 34119075
[TBL] [Abstract][Full Text] [Related]
31. A preliminary benefit-risk assessment of varenicline in smoking cessation.
Cahill K; Stead L; Lancaster T
Drug Saf; 2009; 32(2):119-35. PubMed ID: 19236119
[TBL] [Abstract][Full Text] [Related]
32. Effectiveness of Varenicline and Cytisine for Alcohol Use Reduction Among People With HIV and Substance Use: A Randomized Clinical Trial.
Tindle HA; Freiberg MS; Cheng DM; Gnatienko N; Blokhina E; Yaroslavtseva T; Bendiks S; Patts G; Hahn J; So-Armah K; Stein MD; Bryant K; Lioznov D; Krupitsky E; Samet JH
JAMA Netw Open; 2022 Aug; 5(8):e2225129. PubMed ID: 35930287
[TBL] [Abstract][Full Text] [Related]
33. A randomized, placebo-controlled trial of varenicline, a selective alpha4beta2 nicotinic acetylcholine receptor partial agonist, as a new therapy for smoking cessation in Asian smokers.
Tsai ST; Cho HJ; Cheng HS; Kim CH; Hsueh KC; Billing CB; Williams KE
Clin Ther; 2007 Jun; 29(6):1027-39. PubMed ID: 17692719
[TBL] [Abstract][Full Text] [Related]
34. Cost effectiveness of interventions to reduce relapse to smoking following smoking cessation.
Taylor M; Leonardi-Bee J; Agboola S; McNeill A; Coleman T
Addiction; 2011 Oct; 106(10):1819-26. PubMed ID: 21561499
[TBL] [Abstract][Full Text] [Related]
35. Cytisine versus nicotine for smoking cessation.
Walker N; Howe C; Glover M; McRobbie H; Barnes J; Nosa V; Parag V; Bassett B; Bullen C
N Engl J Med; 2014 Dec; 371(25):2353-62. PubMed ID: 25517706
[TBL] [Abstract][Full Text] [Related]
36. Interventions to increase adherence to medications for tobacco dependence.
Hollands GJ; McDermott MS; Lindson-Hawley N; Vogt F; Farley A; Aveyard P
Cochrane Database Syst Rev; 2015 Feb; (2):CD009164. PubMed ID: 25914910
[TBL] [Abstract][Full Text] [Related]
37. Nicotine preloading for smoking cessation: the Preloading RCT.
Aveyard P; Lindson N; Tearne S; Adams R; Ahmed K; Alekna R; Banting M; Healy M; Khan S; Rai G; Wood C; Anderson EC; Ataya-Williams A; Attwood A; Easey K; Fluharty M; Freuler T; Hurse M; Khouja J; Lacey L; Munafò M; Lycett D; McEwen A; Coleman T; Dickinson A; Lewis S; Orton S; Perdue J; Randall C; Anderson R; Bisal N; Hajek P; Homsey C; McRobbie HJ; Myers-Smith K; Phillips A; Przulj D; Li J; Coyle D; Coyle K; Pokhrel S
Health Technol Assess; 2018 Aug; 22(41):1-84. PubMed ID: 30079863
[TBL] [Abstract][Full Text] [Related]
38. Budgetary impact of varenicline in smoking cessation in the United Kingdom.
Taylor DC; Chu P; Rosen VM; Baker CL; Thompson D
Value Health; 2009; 12(1):28-33. PubMed ID: 18637141
[TBL] [Abstract][Full Text] [Related]
39. Systematic review of the cost-effectiveness of varenicline vs. bupropion for smoking cessation.
Mahmoudi M; Coleman CI; Sobieraj DM
Int J Clin Pract; 2012 Feb; 66(2):171-82. PubMed ID: 22257042
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
